|
|
| | Sipoglitazar Basic information |
| Product Name: | Sipoglitazar | | Synonyms: | Sipoglitazar;3-[3-Ethoxy-1-[4-(2-phenyl-4-thiazolylMethoxy)benzyl]-1H-pyrazol-4-yl]propionic Acid;3-[3-Ethoxy-1-[4-[(2-phenyl-1,3-thiazol-4-yl)Methoxy]benzyl]-1H-pyrazol-4-yl]propionic Acid;3-Ethoxy-1-[[4-[(2-phenyl-4-thiazolyl)Methoxy]phenyl]Methyl]-1H-pyrazole-4-propanoic Acid;CS-1568;1H-Pyrazole-4-propanoic acid, 3-ethoxy-1-[[4-[(2-phenyl-4-thiazolyl)methoxy]phenyl]methyl]-;TAK 654;TAK654 | | CAS: | 342026-92-0 | | MF: | C25H25N3O4S | | MW: | 463.5487 | | EINECS: | | | Product Categories: | | | Mol File: | 342026-92-0.mol |  |
| | Sipoglitazar Chemical Properties |
| Melting point | 111-112oC | | storage temp. | -20°C Freezer | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | color | White |
| | Sipoglitazar Usage And Synthesis |
| Uses | Sipoglitazar is a novel antidiabetic agent. Sipoglitazar displays triple agonistic activities on the human peroxisome proliferator-activated receptors, hPPAR-γ, -α, and -δ. |
| | Sipoglitazar Preparation Products And Raw materials |
|